SkinBioTherapeutics plc (AIM:SBTX)
London
· Delayed Price · Currency is GBP · Price in GBX 11.98
-0.52 (-4.16%)
Mar 9, 2026, 4:28 PM GMT
SkinBioTherapeutics Revenue
In the fiscal year ending June 30, 2025, SkinBioTherapeutics had annual revenue of 4.64M GBP with 283.74% growth. SkinBioTherapeutics had revenue of 3.06M in the half year ending June 30, 2025, with 5,459.30% growth.
Revenue
4.64M
Revenue Growth
+283.74%
P/S Ratio
6.98
Revenue / Employee
113.13K
Employees
41
Market Cap
32.40M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ImmuPharma | -69.96K |
| Arecor Therapeutics | 5.06M |
| Aptamer Group | 1.20M |
| Ondine Biomedical | 1.18M |
| hVIVO | 54.47M |
| Faron Pharmaceuticals Oy | 1.14M |
| Fusion Antibodies | 1.60M |
| Bioventix | 13.12M |